Opera Bioscience SBIR Phase I: A low-cost, bacterial production platform for the manufacturing of high purity recombinant proteins and growth factors
ABSTRACT The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase I project is to introduce a cost-effective way to produce recombinant proteins and growth factors for the cultivated meat industry. Cultivating animal cells to create animal tissues, including... Read More →
Opera Bioscience SBIR Phase I
The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase I project is to introduce a cost-effective way to produce recombinant proteins and growth factors for the cultivated meat industry. Cultivating animal cells to create animal tissues, including muscle... Read More →
4 Houston startups selected for preeminent medtech accelerator
our Houston startups have been selected for the 2023 cohort of the MedTech Innovator’s four-month accelerator program. Los Angeles-based MedTech Innovator, which bills itself as the world’s largest medtech accelerator, will award $800,000 in funding to winners of its competitions... Read More →
MedTech Innovator chooses 3 Minnesota startups for global accelerator
Three Minnesota-based medical startups were chosen among the 61 global companies selected for MedTech Innovator’s four-month accelerator program, which will get started at a summit in Mountain View, California Wednesday. The accelerator provides the winners with $800,000 in non-dilutive funding,... Read More →
Four Irish start-ups bag spots in MedTech Innovator 2023
Galway-based Mirai and Plio as well as Dublin’s Pumpinheart and Xtremedy will accelerate with the MedTech Innovator starting next week. Four Irish start-ups are headed to California this month after making it into the final cohort of MedTech Innovator’s global... Read More →
Nutromics bags $7M in pre-Series A funding
It is currently conducting an in-human trial of its diagnostic patch. Photo courtesy of Nutromics Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year. WHAT IT’S FOR The company has... Read More →
Prenosis Inc. Receives BARDA Contract to Study Utility of Its Sepsis Diagnostic Tool
The Sepsis ImmunoScore™ is a pathogen-agnostic, host-based digital diagnostic that uses Artificial Intelligence/Machine Learning (AI/ML) to predict sepsis based on a combination of clinical parameters and protein biomarkers CHICAGO, June 7, 2023 /PRNewswire/ — Prenosis Inc., an artificial intelligence company... Read More →
RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product
This grant will fund the completion of the company’s pre-clinical development program and pave the way to initiate a clinical trial. LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research... Read More →
Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™
NASHVILLE, Tenn., June 6, 2023 /PRNewswire/ — Candesant Biomedical, Inc. (“Candesant”), a private medical device company focused on the development and commercialization of non-invasive treatments for hyperhidrosis or excessive sweating, today announced the closing of a Series B financing, raising... Read More →
Xtremedy Medical: Zapping wound infections to accelerate healing
Founded in 2020, Galway-based Xtremedy is raising seed funding to start clinical trials for its novel medical device to treat diabetic foot infections. Lyn Markey first met Camille O’Malley at the BioInnovate Ireland fellowship programme in 2018, as part of... Read More →